Progress in vitreoretinal surgery for proliferative diabetic retinopathy

Seminars in Ophthalmology

Volumn 16, Issue 1, 2001, Pages 31-40

  Gotzaridis, Eustratios V ^a   Lit, Eugene S ^a   D'Amico, Donald J ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

CONFERENCE PAPER; DIABETIC RETINOPATHY; ERBIUM YAG LASER; HUMAN; IRIS RUBEOSIS; NEOVASCULAR GLAUCOMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA HEMORRHAGE; RETINA NEOVASCULARIZATION; RETINA SURGERY; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; VITRECTOMY; VITREOUS HEMORRHAGE;

DIABETIC RETINOPATHY; HUMANS; RETINA; VITRECTOMY; VITREORETINOPATHY, PROLIFERATIVE; VITREOUS BODY;

EID: 0035709350     PISSN: 08820538     EISSN: None     Source Type: Journal    
DOI: 10.1076/soph.16.1.31.4218     Document Type: Conference Paper

References (45)

1. Proliferative diabetic retinopathy. Pathophysiology of extraretinal complications and principles of vitreous surgery
2. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. DRVS Report 2
3. Vitrectomy for diabetic vitreous hemorrhage
4. Vitrectomy for complications of diabetic retinopathy
5. Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. DRVS Report 3
6. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four year results of a randomized trial. DRVS Report 5
7. Diabetic traction detachment
8. Diabetic traction retinal detachments threatening the fovea and panretinal argon laser photocoagulation
9. Pars plana vitrectomy techniques for relief of epiretinal traction by membrane segmentation
10. "En block" excision of diabetic membranes
11. Vitrectomy for diabetic traction retinal detachnment involving the macula
12. Diabetic traction retinal detachment: Factors influencing final visual acuity
13. Pars plana vitrectomy for diabetic traction retinal detachment
14. Vitrectomy for diabetic rhegmatogenous retinal detachment
15. Diabetic dence premacular hemorrhage
16. Timing of vitrectomy for active Proliferative diabetic retinopathy
17. Anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy
18. Clinicopathologic findings in anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy
19. Ghost cells as a cause of glaucoma
20. Ghost cell glaucoma following trauma
21. Erbium:YAG laser surgery of the vitreous and retina
22. Initial clinical experience with an erbium:YAG laser for vitreoretinal surgery
23. Multicenter clinical experience using an erbium:YAG laser for vitreoretinal surgery
24. Erbium:YAG laser vitrectomy: Clinical results
25. Comparison of erbium:yttrium-aluminum-garnet-laser vitrectomy and mechanical vitrectomy: A clinical study
26. Treatment of giant tears after perforating injuries with vitrectomy and a cyanoacrylate tissue adhesive
27. Transvitreal cyanoacrylate retinopexy in the management of complicated retinal detachment
28. Cyanoacrylate tissue adhesive in the management of recurrent retinal detachment caused by macular hole
29. The management of retinal detachments associated with choroidal colobomas by vitreous surgery
30. Cyanoacrylate glue in the repair of retinal detachment associated with posterior retinal breaks in infants and children
31. Aron alpha a Sanyo, Japanese tissue adhesive in surgery of internal organs
32. Enzyme assisted vitrectomy with hyaluronidase
33. Hyaluronidase for intravitreal use in an animal model
34. Pharmacologic induction of PVD in the rabbit
35. Successful closure of traumatic macular holes without adjutant
36. A new approach to stage 3 macular hole
37. Posterior vitreous detachment with dispace
38. Chondroitinase-mediated disinsection of the primate vitreous body
39. Studies on enzyme assisted vitrectomy with hyaluronidase
40. Efficacy and safety of enzymatic posterior vitreous detachment by intravitreal injection of hyaluronidase
41. Enzyme assisted vitrectomy with hyaluronidase
42. Hyaluronidase for intravitreal use in an animal model
43. Tissue plaminogen activator as a biochemical adjuvant in vitrectomy for proliferative diabetic vitreoretinopathy
44. Enzymatically induced posterior vitreous detachment in proliferative diabetic vitreoretinopathy